By: Sophie Schmitz, Akshay Kumar, Joanna Fernandes, Chloe Sheppard, Srishti Gupta, Andrea Bernardini, Fisentzos Stylianou, Olivia Johns, Priyanka Kiritharan & Jodie Lyons Introduction In 2022
By: Sophie Schmitz, Akshay Kumar, Richard Wang, Fisentzos Stylianou, Adama Anozie, Chloe Sheppard, Nadia Al Lahiq, Andrea Bernardini & Sylwia Lach Introduction 2021 saw the
By: Richard Wang, Adama Anozie Akshay Kumar & Bruce Chin What is Hospital Exemption? In recent years, we have seen rapid commercial development of advanced
In January 2018, the European Commission released a legislative proposal on Health Technology Assessment (HTA) with the overarching goal to strengthen cooperation among national HTA
Why embrace them? By Chloe Sheppard, Erfan Akbraian, Andrea Bernardini & Richard Wang Advanced Therapy Medicinal Products (ATMPs) have significant potential to transform the lives
Are they as beneficial to manufacturers as they seem? By Joana Fernandes & Ashkay Kumar What are the research aims? Products that are being reviewed
Are they right for your therapy? By Maximus Rex & Nicola Allen Drug development is a long and costly process. It is not uncommon for
2019 set the tone for innovative therapies in the cell and gene therapy space along with huge interest from Big Biotech. With an expected double
“Cross border access”, “hub models”, “highly centralised access models” are only a few buzz words to refer to the pathway that enables European Union (EU)
